Israeli Health-Tech Industry Shows Export Stability Amid Sharp Investment Decline in 2025
How 2 Israeli newsrooms covered this story — translated into English and compared side by side.
First reported by Globes · 1 day ago
What happened
Israel's Health-Tech sector experienced a 40% drop in private investments in 2025, reaching the lowest in five years, yet maintained stability in exports and company activity. The industry saw a decline in medical device funding but growth in AI investments. IATI's CEO highlighted challenges from geopolitical tensions and currency issues but stressed the sector's resilience and global leadership potential.
- 01Private investments in Israeli Health-Tech fell 40% in 2025 to $1.6 billion, the lowest in five years.
- 02Average deal size dropped below $10 million, with medical device funding declining sharply.
- 03Biomedical investments remained stable, while AI-related health-tech investments grew significantly.
- 04Industry stability persists in active companies, exports, and mergers despite investment challenges.
- 05IATI urges enhancing Israel's investment appeal and security to sustain life sciences growth.
- 06Efforts continue to encourage startups to incorporate in Israel and expand international collaborations.
Summary translated & synthesized from the sources below by baba. Read each original for the full report.
Full coverage · 2 outlets
The same event, reported separately by each newsroom. Open a few to compare what each emphasizes — and what they leave out.
